Respiratory failure in tetanus: Case report and review of a 25-year experience

Chest

Volumn 122, Issue 4, 2002, Pages 1488-1492

  Bunch, T Jared ^a   Thalji, Muna K ^a   Pellikka, Patricia A ^a   Aksamit, Timothy R ^a  

^a MAYO CLINIC   (United States)

Author keywords

Respiratory; Respiratory failure; Tetanus

Indexed keywords

BACLOFEN; CEFALEXIN; CEFAZOLIN; CISATRACURIUM; DANTROLENE; FENTANYL; LORAZEPAM; METRONIDAZOLE; TETANUS TOXOID;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; CONVALESCENCE; DEBRIDEMENT; DISEASE COURSE; DYSPNEA; FEMALE; HICCUP; HUMAN; INTUBATION; LACERATION; LARYNX SPASM; MALE; PLEURISY; PRIORITY JOURNAL; RESPIRATORY FAILURE; SECONDARY IMMUNE RESPONSE; STAPHYLOCOCCUS INFECTION; TETANUS; TREATMENT OUTCOME; TRISMUS;

EID: 0036432023     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.122.4.1488     Document Type: Article

References (32)

1. Farrar JJ, Yen LM, Cook T, et al. Tetanus. J Neurol Neurosurg Psychiatry 2000; 69:292-301
2. Ernst ME, Klepser ME, Fouts M, et al. Tetanus: pathophysiology and management. Ann Pharmacother 1997; 31:1507-1513
3. Tetanus: United States, 1985-1986. MMWR Morb Mortal Wkly Rep 1987; 36:477-481
4. LaForce FM, Young LS, Bennett JV. Tetanus in the United States (1965-1966): epidemiologic and clinical features. N Engl J Med 1969; 280:569-574
5. Kefer MP. Tetanus. Am J Emerg Med 1992; 10:445-448
6. Bleck TP. Pharmacology of tetanus. Clin Neuropharmacol 1986; 9:103-120
7. Bleck TP. Tetanus: pathophysiology, management, and prophylaxis. Dis Mon 1991; 37:545-603
8. Alfery DD, Rauscher LA. Tetanus: a review. Crit Care Med 1979; 7:176-181
9. Kerr JH, Corbett JL, Prys-Roberts C, et al. Involvement of the sympathetic nervous system in tetanus: studies on 82 cases. Lancet 1968; 2:236-241
10. Rothstein RJ, Baker FJ. Tetanus: prevention and treatment. JAMA 1978; 240:675-676
11. Rie MA, Wilson RS. Morphine therapy controls autonomic hyperactivity in tetanus. Ann Intern Med 1978; 88:653-654
12. Rocke DA, Wesley AG, Pather M, et al. Morphine in tetanus: the management of sympathetic nervous system overactivity. S Afr Med J 1986; 70:666-668
13. Muller H, Borner U, Zierski J, et al. Intrathecal baclofen in tetanus. Lancet 1986; 1:317-318
14. Pellanda A, Caldiroli D, Vaghi GM, et al. Treatment of severe tetanus by intrathecal infusion of baclofen [letter]. Intensive Care Med 1993; 19:59
15. Farquhar I, Hutchinson A, Curran J. Dantrolene in severe tetanus. Intensive Care Med 1988; 14:249-250
16. Sternlo JE, Andersen LW. Early treatment of mild tetanus with dantrolene. Intensive Care Med 1990; 16:345-346
17. Tidyman M, Prichard JG, Deamer RL, et al. Adjunctive use of dantrolene in severe tetanus. Anesth Analg 1985; 64:538-540
18. Fassoulaki A, Eforakopoulou M. Vecuronium in the management of tetanus: is it the muscle relaxant of choice? Acta Anaesthesiol Belg 1988; 39:75-78
19. Powles AB, Ganta R. Use of vecuronium in the management of tetanus. Anaesthesia 1985; 40:879-881
20. James MF, Manson ED. The use of magnesium sulphate infusions in the management of very severe tetanus. Intensive Care Med 1985; 11:5-12
21. Wesley AG, Hariparsad D, Pather M, et al. Labetalol in tetanus: the treatment of sympathetic nervous system overactivity. Anaesthesia 1983; 38:243-249
22. Ahmadsyah I, Salim A. Treatment of tetanus: an open study to compare the efficacy of procaine penicillin and metronidazole. BMJ 1985; 291:648-650
23. Yen LM, Dao LM, Day NPJ, et al. Management of tetanus: a comparison of penicillin and metronidazole. Paper presented at: Symposium of Antimicrobial Resistance in southern Viet Nam, 1997
24. Dietz V, Milstien JB, van Loon F, et al. Performance and potency of tetanus toxoid: implications for eliminating neonatal tetanus. Bull World Health Organ 1996; 74:619-628
25. Alagappan K, Rennie W, Kwiatkowski T, et al. Seroprevalence of tetanus antibodies among adults older than 65 years. Ann Emerg Med 1996; 28:18-21
26. Wesche HA, Overfield T. Tetanus immunity in older adults. Public Health Nurs 1992; 9:125-127
27. Murphy SM, Hegarty DM, Feighery CS, et al. Tetanus immunity in elderly people. Age Ageing 1995; 24:99-102
28. Gergen PJ, McQuillan GM, Kiely M, et al. A population-based serologic survey of immunity to tetanus in the United States. N Engl J Med 1995; 332:761-766
29. Tetanus: United States, 1987-1988. MMWR Morb Mortal Wkly Rep 1990; 39:37-41
30. General recommendation on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1994; 43:1-38
31. Guide for Adult Immunization. 3rd ed. Philadelphia, PA: American College of Physicians; 1994
32. Simonsen O, Badsberg JH, Kjeldsen K, et al. The fall-off in serum concentration of tetanus antitoxin after primary and booster vaccination. Acta Pathol Microbiol Immunol Scand 1986; 94:77-82